Search Results - LeAnne T. Bloedon

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Flaxseed and Cardiovascular Risk

    Flaxseed and Cardiovascular Risk by LeAnne T. Bloedon, Philippe Szapary

    Published 2004
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome

    Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome by Frederick F. Samaha, Philippe Szapary, Nayyar Iqbal, Monica Williams, LeAnne T. Bloedon, Arshneel Kochar, Megan L. Wolfe, Daniel J. Rader

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial

    Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial by Richard L. Dunbar, Rajesh Movva, LeAnne T. Bloedon, Danielle Duffy, Robert B. Norris, Mohamad Navab, Alan M. Fogelman, Daniel J. Rader

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance

    Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance by Harold Bays, LeAnne T. Bloedon, Grace Lin, Heather Powell, Michael J. Louie, Stephen J. Nicholls, A. Michael Lincoff, Steven E. Nissen

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

    Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol by Kausik K. Ray, Harold Bays, Alberico L. Catapano, Narendra D. Lalwani, LeAnne T. Bloedon, Lulu Ren Sterling, Paula Robinson, Christie M. Ballantyne

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance

    Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance by Ulrich Laufs, Maciej Banach, G.B. John Mancini, Daniel Gaudet, LeAnne T. Bloedon, Lulu Ren Sterling, Stephanie Kelly, Erik S.G. Stroes

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial

    Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial by Debbie L. Cohen, LeAnne T. Bloedon, Rand L. Rothman, John T. Farrar, Mary Lou Galantino, Sheri Volger, Christine Mayor, Phillipe Szapary, Raymond R. Townsend

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome

    Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome by Philippe Szapary, LeAnne T. Bloedon, Frederick F. Samaha, Danielle Duffy, Megan L. Wolfe, Daniel Soffer, Muredach P. Reilly, Jesse Chittams, Daniel J. Rader

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol

    Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol by Margaret E. Brousseau, Ernst J. Schaefer, Megan L. Wolfe, LeAnne T. Bloedon, Andrés Digenio, Ronald W. Clark, James P. Mancuso, Daniel J. Rader

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

    Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients by LeAnne T. Bloedon, Richard L. Dunbar, Danielle Duffy, Paula Pinell-Salles, R. P. Norris, Bruce DeGroot, Rajesh Movva, Mohamad Navab, Alan M. Fogelman, Daniel J. Rader

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Inhibition of Microsomal Triglyceride Transfer Protein in Familial Hypercholesterolemia

    Inhibition of Microsomal Triglyceride Transfer Protein in Familial Hypercholesterolemia by Marina Cuchel, LeAnne T. Bloedon, Philippe Szapary, Daniel M. Kolansky, Megan L. Wolfe, Antoine Sarkis, John S. Millar, Katsunori Ikewaki, Evan S. Siegelman, Richard E. Gregg, Daniel J. Rader

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease

    Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease by Anne C. Goldberg, Lawrence A. Leiter, Erik S.G. Stroes, Seth J. Baum, Jeffrey C. Hanselman, LeAnne T. Bloedon, Narendra D. Lalwani, Pragna Patel, Xin Zhao, P. Barton Duell

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women,,

    Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women,, by LeAnne T. Bloedon, A. Robert Jeffcoat, Wlodek Lopaczynski, Michael J. Schell, Tracy Black, Kelly J. Dix, Brian F. Thomas, Craig D. Albright, Marjorie G. Busby, James A. Crowell, Steven H. Zeisel

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men,,

    Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men,, by Marjorie G. Busby, A. Robert Jeffcoat, LeAnne T. Bloedon, Matthew Koch, Tracy Black, Kelly J. Dix, William D. Heizer, Brian F. Thomas, Judith M. Hill, James A. Crowell, Steven H. Zeisel

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials

    Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials by Harold Bays, Maciej Banach, Alberico L. Catapano, P. Barton Duell, Antonio M. Gotto, Ulrich Laufs, Lawrence A. Leiter, G.B. John Mancini, Kausik K. Ray, LeAnne T. Bloedon, William J. Sasiela, Zhan Ye, Christie M. Ballantyne

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

    Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia by Dirk Blom, Maurizio Averna, Emma A. Meagher, Hendrik du Toit Theron, Cesare R. Sirtori, Robert A. Hegele, Prediman K. Shah, Daniel Gaudet, Claudia Stefanutti, Giovanni Battista Vigna, Dominique Larrey, LeAnne T. Bloedon, Pamela Foulds, Daniel J. Rader, Marina Cuchel

    Published 2017
    Get full text
    Carta
    Save to List
    Saved in:
  17. 17
    Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials

    Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials by Ulrich Laufs, Christie M. Ballantyne, Maciej Banach, Harold Bays, Alberico L. Catapano, P. Barton Duell, Anne C. Goldberg, Antonio M. Gotto, Lawrence A. Leiter, Kausik K. Ray, LeAnne T. Bloedon, Diane MacDougall, Yang Zhang, G.B. John Mancini

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, single-arm, open-label trial

    The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, singl... by Claudia Stefanutti, Dirk Blom, Maurizio Averna, Emma A. Meagher, Hendrik d Theron, A. David Marais, Robert A. Hegele, Cesare R. Sirtori, Prediman K. Shah, Daniel Gaudet, Giovanni Battista Vigna, Bruce S. Sachais, S. Di Giacomo, Anna M.E. Du Plessis, LeAnne T. Bloedon, John Balser, Daniel J. Rader, Marina Cuchel

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

    Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study by Marina Cuchel, Emma A. Meagher, Hendrik du Toit Theron, Dirk Blom, A. David Marais, Robert A. Hegele, Maurizio Averna, Cesare R. Sirtori, Prediman K. Shah, Daniel Gaudet, Claudia Stefanutti, Giovanni Battista Vigna, Anna ME Du Plessis, Kathleen J. Propert, William J. Sasiela, LeAnne T. Bloedon, Daniel J. Rader

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: